Morgan Stanley Knock-Out PPGN/ DE000MG0H0F8 /
| 11/11/2024 4:23:37 PM | Chg.-0.05 | Bid10:00:38 PM | Ask10:00:38 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.17EUR | -4.10% | - Bid Size: - |
- Ask Size: - |
POLYPEPTIDE N | 19.8449 CHF | 12/31/2078 | Call |
GlobeNewswire
8/31
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates
GlobeNewswire
8/13
Meso Numismatics, a Renowned Leader in Regenerative Medical, Announces Global Stem Cells Groups (GSC...
GlobeNewswire
8/5
Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire
7/8
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...
GlobeNewswire
6/5
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at th...
GlobeNewswire
5/13
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire
5/8
ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...
GlobeNewswire
3/29
Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
GlobeNewswire
3/14
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Upda...
GlobeNewswire
3/5
Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action ...
GlobeNewswire
1/10
NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK
GlobeNewswire
1/4
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. M...
GlobeNewswire
12/14/2023
Vandria Announces $20.6M (CHF18M) Series A Financing Led by ND Capital to Drive CNS Clinical Program...
GlobeNewswire
12/1/2023
Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Al...
GlobeNewswire
11/27/2023
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglut...
GlobeNewswire
11/2/2023
Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral G...
GlobeNewswire
10/2/2023
Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry Inhi...
GlobeNewswire
9/19/2023
Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Mee...
GlobeNewswire
8/31/2023
Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates
Newsfile Corp
8/16/2023
Polypeptide.ltd Announces Intent to Expand Tirzepatide and Retatrutide to Production Capacity of Hig...
Newsfile Corp
5/1/2023
KeraFactor(TM) Introduces an Unprecedented Laser-Assisted Topical Delivery Solution
